isomorphic labs deepmind - Search News

Alphabet, Isomorphic and AI drug discovery

‘Solving All Disease’ Using AI is the Mission of Alphabet’s Isomorphic Labs – Its $600M in Funding Will Help

Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical programs, and accelerate disease research.

TechCrunch on MSN · 4d

Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

The New York Times · 4d

Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital as a backer.

Crunchbase News4d

Alphabet-Backed Isomorphic Labs Raises $600M For AI Drug Development

Google spinoff Isomorphic Labs raised $600 million in its first external funding round as the company looks to apply ...

3don MSN

Demis Hassabis on Isomorphic’s $600 million raise, AI, and healthcare’s future

Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results